Companies / Vertex Pharmaceuticals Inc / Ma / Activity
Activity — Vertex Pharmaceuticals Inc / Ma
144 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Sachdev Amit Executive | Sell | Common Stock | $9.21M | -20K -19.32% | 82,124 0.03% of shares | medium |
| Feb 27, 2026 | Kewalramani Reshma CEO | Sell | Common Stock | $7.72M | -16K -12.81% | 105,998 0.04% of shares | medium |
| Feb 13, 2026 | Kewalramani Reshma CEO | Other | Common Stock | $6.36M | -13K -8.90% | 133,487 0.05% of shares | low |
| Feb 19, 2026 | Sachdev Amit Executive | Sell | Common Stock | $5.51M | -12K -15.64% | 63,171 0.02% of shares | medium |
| Feb 19, 2026 | Sachdev Amit Executive | Sell | Common Stock | $4.80M | -10K -9.16% | 101,786 0.04% of shares | medium |
| Feb 19, 2026 | Sachdev Amit Executive | Exercise | Common Stock | $4.69M | +25K +27.05% | 117,547 0.05% of shares | low |
| Jan 6, 2026 | Wagner Charles F Jr Executive | Sell | Common Stock | $4.39M | -10K -20.17% | 37,725 0.01% of shares | medium |
| Feb 10, 2026 | Kewalramani Reshma CEO | Other | Common Stock | $3.89M | -8K -5.36% | 146,528 0.06% of shares | low |
| Feb 19, 2026 | Sachdev Amit Executive | Exercise | Common Stock | $3.65M | +23K +34.01% | 92,521 0.04% of shares | low |
| Feb 19, 2026 | Sachdev Amit Executive | Sell | Common Stock | $3.40M | -7K -8.82% | 74,883 0.03% of shares | medium |
| Feb 17, 2026 | Kewalramani Reshma CEO | Other | Common Stock | $3.17M | -7K -4.37% | 143,259 0.06% of shares | low |
| Feb 27, 2026 | Kewalramani Reshma CEO | Sell | Common Stock | $2.97M | -6K -5.66% | 100,003 0.04% of shares | medium |
| Feb 24, 2026 | Kewalramani Reshma CEO | Other | Common Stock | $2.42M | -5K -3.48% | 138,278 0.05% of shares | low |
| Feb 13, 2026 | Wagner Charles F Jr Executive | Other | Common Stock | $2.23M | -5K -9.46% | 43,715 0.02% of shares | low |
| Jan 7, 2026 | Tatsis Ourania Executive | Sell | Common Stock | $2.14M | -5K -9.62% | 42,293 0.02% of shares | medium |
| Feb 19, 2026 | Sachdev Amit Executive | Sell | Common Stock | $2.00M | -4K -6.71% | 58,934 0.02% of shares | medium |
| Feb 13, 2026 | Bozic Carmen Executive | Other | Common Stock | $1.86M | -4K -9.09% | 38,053 0.02% of shares | low |
| Feb 13, 2026 | Tatsis Ourania Executive | Other | Common Stock | $1.86M | -4K -7.40% | 47,632 0.02% of shares | low |
| Jan 6, 2026 | Wagner Charles F Jr Executive | Exercise | Common Stock | $1.81M | +10K +25.27% | 47,257 0.02% of shares | low |
| Feb 13, 2026 | Sachdev Amit Executive | Other | Common Stock | $1.73M | -4K -5.15% | 65,393 0.03% of shares | low |
| Feb 27, 2026 | Kewalramani Reshma CEO | Sell | Common Stock | $1.73M | -3K -2.80% | 121,578 0.05% of shares | medium |
| Feb 24, 2026 | Leiden Jeffrey M Executive | Other | Common Stock | $1.72M | -4K -9.25% | 34,797 0.01% of shares | low |
| Feb 27, 2026 | Kewalramani Reshma CEO | Sell | Common Stock | $1.60M | -3K -2.43% | 131,730 0.05% of shares | medium |
| Feb 13, 2026 | Biller Jonathan Executive | Other | Common Stock | $1.46M | -3K -14.38% | 17,826 <0.01% of shares | low |
| Feb 18, 2026 | Leiden Jeffrey M Executive | Other | Common Stock | $1.43M | -3K -7.18% | 38,344 0.02% of shares | low |
| Feb 10, 2026 | Wagner Charles F Jr Executive | Other | Common Stock | $1.43M | -3K -5.93% | 48,280 0.02% of shares | low |
| Feb 27, 2026 | Kewalramani Reshma CEO | Sell | Common Stock | $1.34M | -3K -2.08% | 128,545 0.05% of shares | medium |
| Mar 11, 2026 | McKechnie Duncan Executive | Sell | Common Stock | $1.31M | -3K -17.41% | 12,489 <0.01% of shares | medium |
| Feb 19, 2026 | Sachdev Amit Executive | Sell | Common Stock | $1.27M | -3K -2.34% | 113,897 0.04% of shares | medium |
| Feb 27, 2026 | Kewalramani Reshma CEO | Sell | Common Stock | $1.24M | -3K -1.98% | 125,076 0.05% of shares | medium |
| Feb 27, 2026 | Kewalramani Reshma CEO | Sell | Common Stock | $1.22M | -3K -1.83% | 135,008 0.05% of shares | medium |
| Feb 25, 2026 | McKechnie Duncan Executive | Sell | Common Stock | $1.22M | -3K -11.13% | 19,969 <0.01% of shares | medium |
| Feb 17, 2026 | Biller Jonathan Executive | Sell | Common Stock | $1.21M | -2K -12.72% | 16,992 <0.01% of shares | medium |
| Feb 17, 2026 | Bunnage Mark E. Executive | Sell | Common Stock | $1.19M | -2K -20.13% | 9,668 <0.01% of shares | medium |
| Feb 25, 2026 | McKechnie Duncan Executive | Sell | Common Stock | $1.18M | -2K -12.07% | 17,559 <0.01% of shares | medium |
| Mar 4, 2026 | McKechnie Duncan Executive | Sell | Common Stock | $1.16M | -2K -13.88% | 15,122 <0.01% of shares | medium |
| Mar 13, 2026 | Bozic Carmen Executive | Sell | Common Stock | $1.12M | -2K -6.17% | 35,405 0.01% of shares | medium |
| Feb 27, 2026 | Bozic Carmen Executive | Sell | Common Stock | $1.12M | -2K -5.81% | 37,734 0.01% of shares | medium |
| Feb 13, 2026 | Bunnage Mark E. Executive | Other | Common Stock | $1.11M | -2K -17.68% | 10,631 <0.01% of shares | low |
| Feb 13, 2026 | McKechnie Duncan Executive | Other | Common Stock | $1.11M | -2K -10.47% | 19,528 <0.01% of shares | low |
| Feb 17, 2026 | Tatsis Ourania Executive | Other | Common Stock | $1.11M | -2K -4.42% | 49,627 0.02% of shares | low |
| Feb 17, 2026 | Wagner Charles F Jr Executive | Other | Common Stock | $1.11M | -2K -4.49% | 48,786 0.02% of shares | low |
| Mar 27, 2026 | Bozic Carmen Executive | Sell | Common Stock | $1.05M | -2K -6.58% | 33,076 0.01% of shares | medium |
| Feb 17, 2026 | Sachdev Amit Executive | Other | Common Stock | $1.04M | -2K -3.01% | 69,042 0.03% of shares | low |
| Feb 10, 2026 | Bozic Carmen Executive | Other | Common Stock | $1.00M | -2K -4.87% | 41,857 0.02% of shares | low |
| Feb 10, 2026 | Tatsis Ourania Executive | Other | Common Stock | $1.00M | -2K -3.96% | 51,902 0.02% of shares | low |
| Feb 17, 2026 | Atkinson Edward Morrow III Executive | Sell | Common Stock | $994.1K | -2K -8.62% | 21,544 <0.01% of shares | medium |
| Feb 10, 2026 | Sachdev Amit Executive | Other | Common Stock | $963.5K | -2K -2.90% | 68,941 0.03% of shares | low |
| Feb 11, 2026 | Bunnage Mark E. Executive | Sell | Common Stock | $930.5K | -2K -13.53% | 12,914 <0.01% of shares | medium |
| Feb 13, 2026 | Atkinson Edward Morrow III Executive | Other | Common Stock | $928.2K | -2K -8.63% | 20,143 <0.01% of shares | low |